-
IDYA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
IDEAYA Biosciences (IDYA)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 85.18 mm | 85.18 mm | 85.18 mm | 85.18 mm | 85.18 mm | 85.18 mm |
Cash burn (monthly) | 105.34 mm | 6.05 mm | 48.05 mm | 27.25 mm | 40.55 mm | 20.63 mm |
Cash used (since last report) | 299.72 mm | 17.21 mm | 136.71 mm | 77.53 mm | 115.38 mm | 58.71 mm |
Cash remaining | -214.54 mm | 67.97 mm | -51.53 mm | 7.65 mm | -30.20 mm | 26.48 mm |
Runway (months of cash) | -2.0 | 11.2 | -1.1 | 0.3 | -0.7 | 1.3 |
13F holders | Current |
---|---|
Total holders | 208 |
Opened positions | 34 |
Closed positions | 38 |
Increased positions | 93 |
Reduced positions | 54 |
13F shares | Current |
---|---|
Total value | 2.24 tn |
Total shares | 99.15 mm |
Total puts | 24.10 k |
Total calls | 39.60 k |
Total put/call ratio | 0.6 |
Largest owners | Shares | Value |
---|---|---|
FMR | 12.96 mm | $333.15 bn |
BlackRock | 8.38 mm | $215.29 bn |
JHG Janus Henderson | 5.86 mm | $150.61 bn |
Vanguard | 5.08 mm | $130.51 bn |
FHI Federated Hermes | 5.06 mm | $130.13 bn |
T. Rowe Price | 3.87 mm | $99.38 mm |
STT State Street | 3.32 mm | $85.35 bn |
Logos Global Management | 3.00 mm | $77.10 bn |
Deerfield Management | 2.74 mm | $70.32 bn |
Capital Research Global Investors | 2.57 mm | $65.94 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Feb 25 | Michael Anthony White | Stock Option Common Stock | Grant | Acquire A | No | No | 20.24 | 185,000 | 3.74 mm | 185,000 |
27 Feb 25 | Douglas B. Snyder | Stock Option Common Stock | Grant | Acquire A | No | No | 20.24 | 33,000 | 667.92 k | 33,000 |
27 Feb 25 | Hata Yujiro S | Stock Option Common Stock | Grant | Acquire A | No | No | 20.24 | 600,000 | 12.14 mm | 600,000 |
27 Feb 25 | Briseno Andres Ruiz | Stock Option Common Stock | Grant | Acquire A | No | No | 20.24 | 75,000 | 1.52 mm | 75,000 |
27 Feb 25 | Stuart Dorman | Stock Option Common Stock | Grant | Acquire A | No | No | 20.24 | 15,000 | 303.60 k | 15,000 |